Pharmaceutical Executive January 17, 2024
As the technology becomes more ingrained within the Pharma industry’s processes, experts believe that regulation covering the use of AI is coming.
While the technology has been around for several years now, 2023 is the year the AI became a mainstream topic. For the general public, the conversation focused on generative AI, or programs that can generate responses, images, and videos based on user prompts. For the life sciences industry, however, the use of this technology goes beyond that.
In 2023, pharma companies fully embraced the used of AI, both in generative form and as highly complex data sorting algorithms. These programs were implemented across the spectrum of the industry, being included as part of the process from everything to...
Today's Sponsors
Today's Sponsor